Notizie Larimar Therapeutics - LRMR

Ultime notizie

Data	Ora	Fonte	Titolo
11/3/2024	21:09	EDGAR2	Form 8-K - Current report
16/2/2024	22:06	EDGAR2	Form 8-K - Current report
15/2/2024	02:57	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
14/2/2024	23:08	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/2024	14:55	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
14/2/2024	12:06	EDGAR2	Form 8-K - Current report
13/2/2024	22:46	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
12/2/2024	13:03	EDGAR2	Form 8-K - Current report
19/1/2024	22:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/1/2024	22:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/1/2024	22:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
19/1/2024	22:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
08/12/2023	22:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/11/2023	19:51	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/10/2023	22:31	EDGAR2	Form 8-K - Current report
14/8/2023	14:00	EDGAR2	Form 8-K - Current report
10/8/2023	22:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/2023	13:03	EDGAR2	Form 8-K - Current report
25/7/2023	19:06	DJN	Larimar Therapeutics Shares Rise 10% After FDA Clears..
25/7/2023	13:02	EDGAR2	Form 8-K - Current report
18/7/2023	22:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
18/7/2023	22:13	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
17/7/2023	22:08	EDGAR2	Form 8-K - Current report

Apertura: 7,87	Min: 7,43	Max: 7,89
Chiusura: 7,61